SLA Pharma published Fractl's 2026 AI search study surveying 1,008 US consumers and 150 marketers in Q2.
Public source
Publisher name
Public post
Half of marketers say AI made their work faster and more average. Average is a position, not a setting. Fractl's 2026 AI search study surveyed 1,008 US consumers and 150…
Company
SLA Pharma
Pharmaceutical company that specializes in developing Gastrointestinal Medicines
- Industry
- Pharmaceutical Manufacturing
- Location
- Watford, GB
- Company size
- 2–10 employees
About SLA Pharma
SLA Pharma is a niche biopharmaceutical company, specializing in gastrointestinal and allied disorders, with products in clinical development and already approved for human use. SLA Pharma is committed to improving the range of products available to treat gastrointestinal diseases worldwide. SLA Pharma AG is one of the few pharmaceutical companies in the world focused solely on developing medicines for the prevention and treatment of gastrointestinal (GI) disorders. This commitment to developing solutions for GI disorders has made SLA Pharma a world leader in the field through unrivalled development, medical, regulatory and commercial expertise in its therapeutic areas.
See moreDiscover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Brafton Inc.
Brafton Inc. published a survey showing nearly 1 in 5 marketers in 2025 did not use AI.
Research & Knowledge
Orion Pharma
Orion Pharma scientists discovered a novel medicine for patients with prostate cancer and are working in the company's R&D department.
Research & Knowledge
The Association of the British Pharmaceutical Industry (ABPI)
The Association of the British Pharmaceutical Industry (ABPI) published the new UK Pharmaceutical Investment Competitiveness Report 2026, which reveals that since September 2025, £2 billion of new investment has been committed to the UK spanning AI-enabled drug discovery through to large-scale manufacturing.
Research & Knowledge
Fresenius Kabi
Fresenius Kabi published an article by Anthropic titled The AI Native SDLC Playbook, focusing on the build stage of AI content delivery.
Research & Knowledge
Pfizer